Search research articles
Contact Us
Filters
Showing results (21-30 of 155) with videos related to
Page
of 16
Sort By:
Clinical Colorectal Cancer
|
June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors
Lea Jehanno, Julie Henriques, Thomas Samaille, et al.
JCO Oncology Practice
|
March 26, 2026
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting Stoma
Andrea Marques, Julie Henriques, Dewi Vernerey, et al.
International Journal of Molecular Sciences
|
September 22, 2020
Anti-Telomerase CD4<sup>+</sup> Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
Laurie Spehner, Stefano Kim, Angélique Vienot, et al.
BMC Cancer
|
June 21, 2017
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study
Quentin Jacquinot, Nathalie Meneveau, Marion Chatot, et al.
Diseases of the Colon and Rectum
|
October 18, 2005
Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients' characteristics
Lucas Sideris, Franck Zenasni, Dewi Vernerey, et al.
Frontiers in Immunology
|
June 17, 2022
Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
Emilie Gaiffe, Dewi Vernerey, Laurent Bardiaux, et al.
British Journal of Cancer
|
July 13, 2019
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
Edouard Auclin, Thierry André, Julien Taieb, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 27, 2025
Quality Assurance of Stereotactic Irradiation and Survival of Patients With Head and Neck Cancer in the A GORTEC 2014-04 "OMET" Randomized Phase 2 Trial
Pauline Maury, Yann Sayous, Ryan Marnaoui, et al.
Bulletin Du Cancer
|
April 17, 2019
[A GERCOR-AERIO national survey of oncology residents in France: Current setting and expectations regarding post-internship and research]
Marc Hilmi, Benoît Rousseau, Romain Cohen, et al.
Cancer Medicine
|
August 12, 2014
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
Frédéric Fiteni, Thierry Nguyen, Dewi Vernerey, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 155) with videos related to
Sort By:
Page
of 16
Clinical Colorectal Cancer
|
June 12, 2026
Dual CTLA-4/PD-1 Blockade Versus Anti-PD-1 in MSI-H Metastatic Colorectal Cancer: Early Survival Benefit and Exploratory Clinical Predictors
Lea Jehanno, Julie Henriques, Thomas Samaille, et al.
JCO Oncology Practice
|
March 26, 2026
Toxicity of Capecitabine and Oxaliplatin as Adjuvant Therapy for Stage III Colorectal Cancer Patients With Diverting Stoma
Andrea Marques, Julie Henriques, Dewi Vernerey, et al.
International Journal of Molecular Sciences
|
September 22, 2020
Anti-Telomerase CD4<sup>+</sup> Th1 Immunity and Monocytic-Myeloid-Derived-Suppressor Cells Are Associated with Long-Term Efficacy Achieved by Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) in Advanced Anal Squamous Cell Carcinoma: Translational Study of Epitopes-HPV01 and 02 Trials
Laurie Spehner, Stefano Kim, Angélique Vienot, et al.
BMC Cancer
|
June 21, 2017
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study
Quentin Jacquinot, Nathalie Meneveau, Marion Chatot, et al.
Diseases of the Colon and Rectum
|
October 18, 2005
Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients' characteristics
Lucas Sideris, Franck Zenasni, Dewi Vernerey, et al.
Frontiers in Immunology
|
June 17, 2022
Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
Emilie Gaiffe, Dewi Vernerey, Laurent Bardiaux, et al.
British Journal of Cancer
|
July 13, 2019
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
Edouard Auclin, Thierry André, Julien Taieb, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 27, 2025
Quality Assurance of Stereotactic Irradiation and Survival of Patients With Head and Neck Cancer in the A GORTEC 2014-04 "OMET" Randomized Phase 2 Trial
Pauline Maury, Yann Sayous, Ryan Marnaoui, et al.
Bulletin Du Cancer
|
April 17, 2019
[A GERCOR-AERIO national survey of oncology residents in France: Current setting and expectations regarding post-internship and research]
Marc Hilmi, Benoît Rousseau, Romain Cohen, et al.
Cancer Medicine
|
August 12, 2014
Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
Frédéric Fiteni, Thierry Nguyen, Dewi Vernerey, et al.
Page
of 16